
SPARX Global Randomized Controlled Trial by Translumina Initiated to Advance Evidence for Drug-Coated Balloons in Complex Coronary Disease
<a href="https://news.google.com/rss/articles/CBMiowJBVV95cUxOWWxVdFEzbms0TFlmX2VLOWN4dkxFS2hQRVROOVdpbUFGNjlyREM1c0lDOEJ5STlaUjlLMGJaZWEwSG5GLTVTR1U1eHhSYUJYbGxESGZzTi1hSWEzN2ozWnIyTVh5T0ExVVdYVDg1MDdUdEp2R2xGSjlTd3NaOTBkSnlLVEx5S0hac3psSmhySFowbm83cWlfbVJIek1zR2FsZ2pDOHgzWGxXMnRJSzFvdWlzZldsQllzaXdkVl9uNldCUlBLRmRqYkRtNXdkbVZvSmVITUZSXzVDQ3pNdXYtNHZ2V0NKelVqR2hXUWw1TnlsaWxqdUpHZERZXzlfU2YtMFNxOFZIdnJXRTZZd3ZBTEtjNjJnSGVXZkVhOTVyYjdlRW8?oc=5" target="_blank">SPARX Global Randomized Controlled Trial by Translumina Initiated to Advance Evidence for Drug-Coated Balloons in Complex Coronary Disease</a>&nbsp;&nbsp;<font color="#6f6f6f">PR Newswire</font>
